Notice 11 Aug 2025 iowa, controlled substances, regulatory compliance, dea, pharmaceuticals, drug manufacturing

💊Cambrex Charles City Seeks Registration for Controlled Substance Manufacturing

Cambrex Charles City has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Learn More
Notice 8 Aug 2025 compliance, controlled substances, business regulation, drug enforcement, dea, manufacturing

💊Chemtos LLC's Application for Bulk Manufacturing of Controlled Substances

Chemtos, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 25 Jul 2025 compliance, healthcare, dea, florida, drug enforcement, medical regulation

🚫DEA Revokes Registration of Dr. Taha Dias for Prescription Violations

The Drug Enforcement Administration issued a decision to revoke the DEA Certificate of Registration for Dr. Taha Dias, citing repeated violations of federal and Florida state law related to the improper issuance of prescriptions for controlled substances without legitimate medical purpose, jeopardizing public safety and regulatory compliance.

Learn More
Notice 17 Jul 2025 regulatory compliance, pharmaceutical industry, dea, controlled substances, import application

💊DEA Notice

AndersonBrecon, Inc. DBA PCI Pharma Services has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 16 Jul 2025 compliance, healthcare, regulation, colorado, licensing, dea, drug enforcement

🚑DEA Revokes Registration of Diana Clouthier

The Drug Enforcement Administration has revoked the registration of Diana Clouthier, N.P., due to her suspended licenses in Colorado, deeming her unable to handle controlled substances. This decision emphasizes the necessity of maintaining state licensing for healthcare practitioners to comply with federal regulations, highlighting potential risks for businesses operating in the healthcare field.

Learn More
Notice 16 Jul 2025 arizona, regulatory compliance, healthcare, dea, drug enforcement

⚖️DEA Revocation Order

The Drug Enforcement Administration (DEA) has issued an Order to Show Cause against Benson Sergiles, P.A., proposing to revoke its registration for handling controlled substances in Arizona due to a lack of state licensure. The decision underscores the necessity of maintaining valid state authority for healthcare practitioners to dispense controlled substances, highlighting regulatory compliance challenges within the healthcare sector.

Learn More
Notice 16 Jul 2025 compliance, healthcare, regulatory, north carolina, dea, controlled substances, drug enforcement administration

⚖️DEA Revocation

The Drug Enforcement Administration revokes the registration of Sasha Melissa Ikramelahai due to allegations of material falsification and lack of state authority to handle controlled substances in North Carolina. The case underscores the significance of regulatory compliance in the healthcare sector, emphasizing the severe consequences businesses face when failing to uphold licensure integrity.

Learn More
Notice 14 Jul 2025 compliance, healthcare, regulation, pennsylvania, registration, dea, controlled substances, drug enforcement

⚖️High Impact DEA Registration Denial and Compliance Issues

The DEA issued a final order denying Michael Bouknight's applications for DEA registration based on lack of state authority and material falsification in his applications. The ruling highlights the necessity for practitioners to maintain state licensing to handle controlled substances and stresses the importance of integrity in registration processes.

Learn More
Notice 14 Jul 2025 compliance, pennsylvania, registration, dea, controlled substances, pharmacy, public safety

💊DEA Revokes Pharmacy Registration Due to Compliance Failures

The DEA issued an Order to Show Cause and revoked the registration of Just Here II Pharmacy, citing failures to maintain accurate records for dispensing controlled substances, which poses an imminent danger to public health. The decision emphasizes the importance of compliance with federal and state regulations governing the pharmaceutical industry.

Learn More
Notice 14 Jul 2025 compliance, healthcare, regulations, dea, florida, pharmacy

💊Revocation of DEA Registration for JYA LLC - Major Implications

The Department of Justice has revoked the DEA registration of JYA LLC d/b/a Webb's Square Pharmacy due to serious violations, including dispensing controlled substances without legitimate prescriptions. The agency determined that these actions posed an imminent danger to public health, resulting in immediate sanctions and the denial of future registration applications. The ruling underscores the critical importance of compliance in pharmacy practice.

Learn More